Sales rise 17.05% to Rs 435.50 crore
Net profit of Caplin Point Laboratories rose 20.23% to Rs 117.20 crore in the quarter ended December 2023 as against Rs 97.48 crore during the previous quarter ended December 2022. Sales rose 17.05% to Rs 435.50 crore in the quarter ended December 2023 as against Rs 372.07 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales435.50372.07 17 OPM %32.6729.40 -PBDT159.31123.17 29 PBT145.41111.74 30 NP117.2097.48 20Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
